Skip to content
Home/Companies/Pharma/Nycomed

Nycomed

Pharma·Switzerland·Exited 2011·Held 9yr
Entry
2002
Hold
9yr
Exit
2011

Who owns Nycomed?

Nycomed is a Swiss Pharma company, now owned by Takeda, which acquired it in 2011 from Nordic Capital.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Nordic Capital
Investor
Nordic Capital
Nordic Capital (early funds) · 1991 · Buyout

Key facts

HQSwitzerland
SectorPharma
StatusAcquired
Exit Type
Trade Sale
Buyer
Takeda
Exit Year
2011

More from Nordic Capital (early funds)

Other portfolio companies in the same fund.

Bufab
Exited 2014
IndustrialsSweden· 2005
Cloetta
Exited 2013
ConsumerSweden· 2005
FinnvedenBulten
3.0xExited 2011
MobilitySweden· 2005
Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.)
Exited 2012
PharmaUS· 2005
to Sandoz (Novartis)
Kompan
Exited 2014
ConsumerDenmark· 2005
to Christian Dyvig, PFA pension fund and KOMPAN management
Luvata
Exited 2014
IndustrialsFinland· 2005
to Mitsubishi Materials

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Nycomed?

Nycomed is now owned by Takeda, which acquired it in 2011 from Nordic Capital.

When did Takeda acquire Nycomed?

Takeda acquired Nycomed in 2011, buying from Nordic Capital.

Who did Nycomed sell to?

Nordic Capital sold Nycomed to Takeda in 2011 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue